Phase 3 Clinical Trials > Laboratories

Toxikon Corporation is an ISO 1725-accredited global Contract Research Organization (CRO) that conducts safety studies for the medical device and biopharmaceutical industries. With more than 3 years of experience, Toxikon provides testing services to meet FDA/ISO/ICH, OECD, USP and Japan’s MHLW standards. Services include a complete range of PK, TK, ADME and toxicology studies and carcinogenicity, bioavailability, chemical characterization, impurities analysis and synthesis, bioanalytical and microbiology assays.Toxikon operates a 125, square foot facility at their headquarters in Bedford, Massachusetts and has additional offices in the U.S., Europe and Asia. Toxikon maintains a subsidiary in Belgium to facilitate growing demands from international clients.

15 Wiggins Avenue Bedford, MA 01730 USA